Nemaura Medical | Investor Presentation Deck | 22 slides

Nemaura Medical · 2023-09
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

22
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
The slide uses a generic pie chart graphic as a visual metaphor for market segmentation.transition
Open slide detailBeat · ProblemLoop · Logic Chain
04
Uses authority citation (Forbes) to establish the scale of the problem.size_opportunity
Open slide detailBeat · ProblemLoop · Logic Chain
05
The slide uses a product photo to demonstrate the scale and form factor of the device.present_solution
Open slide detailBeat · ProductLoop · Logic Chain
06
show_traction
Open slide detailBeat · ProductLoop · Logic Chain
07
The slide uses a 'Target vs Status' framework to demonstrate progress.show_traction
Open slide detailBeat · ProductLoop · Logic Chain
08
The slide outlines specific milestones including FDA approval, manufacturing scale-up, US market entry, and D2C expansion.plan_implementation
Open slide detailBeat · ProductLoop · Logic Chain
09
The slide presents two line charts: one comparing BGM vs Invasive CGM, and one showing raw sugarBEAT data.show_traction
Open slide detailBeat · ProductLoop · Logic Chain
10
The slide highlights the UI/UX of the companion app for the sugarBEAT CGM device.present_solution
11
The slide uses a pie chart graphic as a visual metaphor for market segmentation, though it does not contain actual data.decompose_segments
12
plan_implementation
13
plan_implementation
14
plan_implementation
15
The superscript 3 in '2000^3' appears to be a typo or formatting error in the source slide.plan_implementation
16
The slide contrasts a large incumbent's metrics with the company's own USP.compare_peers
Open slide detailBeat · Competition
17
The slide outlines CE marking in Europe and the ongoing FDA PMA review process, including specific audit and inspection history.establish_context
18
present_solution
19
The slide uses a numbered list format to present future product roadmap items.plan_implementation
20
present_solution
21
summarize